Stock NWBO NORTHWEST BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Northwest Biotherapeutics, Inc.

Equities

NWBO

US66737P6007

Delayed OTC Markets
Other stock markets
 10:05:15 2024-05-23 EDT 		5-day change 1st Jan Change
0.4584 USD +0.45% Intraday chart for Northwest Biotherapeutics, Inc. -4.42% -34.55%
05-10 Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-21 Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Northwest Biotherapeutics: Q1 Earnings Snapshot
AQ
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors
CI
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors
CI
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
PR
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma
AQ
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma
PR
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma
CI
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
PR
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC
CI
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)
AQ
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application
AQ
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application
PR
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE
AQ
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)
AQ
Penny Stocks Set To Soar On News Watchlist (TBRIF, NWBO, IQST, TLOFF)
AQ
Today's OTC Momentum Watchlist (RGGI, DLOC, NWBO, HMBL)
AQ
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NWBO Stock
  4. News Northwest Biotherapeutics, Inc.